Communiqués Origin Therapeutics Holdings Inc. Canadian Securities Exchange

Actions

ORIG

CA68622H1073

Cours en clôture Canadian Securities Exchange Autres places de cotation 00:00:00 05/02/2024			Varia. 5j.	Varia. 1 janv.
0,115 ^CAD	-11,54%		-14,81%	-39,47%

21/06	Safe Supply Streaming Co Ltd. Démission de Frank Salvati du conseil d'administration	CI
31/05	Safe Supply Streaming Co. Ltd. annonce ses résultats pour le deuxième trimestre et le semestre clos le 31 mars 2024	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Safe Supply Streaming Corp. Announces Resignation of Board Member	21/06	NE
Safe Supply Streaming Corp. Announces Strategic Expansion into AI-Powered Healthcare Solutions	30/05	NE
Safe Supply Streaming Portfolio Company, Safety Strips, Provides Corporate Update	07/05	NE
Safe Supply Streaming: Pioneering Solutions in the Addiction Crisis through Strategic Partnerships and Innovation	02/05	NE
Safe Supply Streaming Portfolio Company, Safety Strips, Launches Non-Brokered Private Placement	26/03	NE
Safe Supply Streaming Announces Closing of the Safety Strips Stake Acquisition and Its Accelerated Commercialization	04/03	NE
Safe Supply Commends B.C. Naturopathic Doctors Association's Effort to Expand Prescription Powers Amid Substance-Use Crisis and Provides Update on Safety Strip Acquisition Transaction Details	21/02	NE
Safe Supply Streaming Announces Landmark Coca Powder and Extract Product Shipment During the Third Wave of Drug Policy Reforms	15/02	NE
Safe Supply Streaming Announces Strategic Acquisition of 7% Stake in Leading Harm Reduction Company Safety Strips Tech Corp. and Provides Corporate Update	08/02	NE
SAFE SUPPLY AND ORIGIN THERAPEUTICS RECEIVE CONDITIONAL APPROVAL FOR LISTING ON THE CSE	12/09/23	GL
SAFE SUPPLY AND ORIGIN THERAPEUTICS RECEIVE CONDITIONAL APPROVAL FOR LISTING ON THE CSE	12/09/23	AQ
Origin Therapeutics Announces Results of Annual General and Special Meeting of Shareholders	05/09/23	GL
SAFE SUPPLY AND ORIGIN THERAPEUTICS ANNOUNCE SIGNING OF DEFINITIVE AGREEMENT	02/08/23	GL
Origin Therapeutics Announces Closing of Safe Supply Subscription Receipt Financing	02/08/23	GL
SAFE SUPPLY AND ORIGIN THERAPEUTICS ANNOUNCES ENGAGEMENT OF RESEARCH CAPITAL AND UPSIZING OF BROKERED FINANCING TO $4 MILLION	02/03/23	GL
Origin Enters into Binding Letter of Intent with Safe Supply Streaming Co., a Pharmaceutical and Narcotics Investment Company with a First Mover Advantage in the Safe Supply Narcotics Sector	31/01/23	GL
IIROC Trading Halt - ORIG	31/01/23	AQ
Origin Therapeutics Announces New Director	01/11/22	GL
Origin Therapeutics Announces New Director	01/11/22	AQ
Origin Therapeutics’ Portfolio Company, Clairvoyant, Approved for Phase 2 Psilocybin Therapy Trial; First Clinical Site Initiated in Finland	19/10/22	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Origin Therapeutics Holdings Inc. Canadian Securities Exchange

Actions

ORIG

CA68622H1073

Communiqués

Filtres